Preprint
Article

This version is not peer-reviewed.

Assessing of Virulent Factor Genes in Pig-Derived Escherichia coli from VOJVODINA region and Their Treatment with Postbiotic Substance and Herbal Essential Oils

A peer-reviewed article of this preprint also exists.

Submitted:

17 December 2025

Posted:

18 December 2025

You are already at the latest version

Abstract

Altogether 16 pigs-derived Escherichia coli (isolated pig farms in Vojvodina region, Serbia) were taxonomically identified using MALDI-TOF mass spectrometry; 14 (87.5%) with secure genus identification/probable species identification and two with highly probable genus identification. Testing virulence factor genes, the gene fimA was detected in 62.5% of strains. Crl gene was detected in 14 strains (87.5 %). Ec3419/2 contained 5 analyzed genes. Using Congo red agar, five E. coli were biofilm-forming which was not confirmed using the quantitative plate assay. The strains were mostly multiresistnt to antibiotics. Each E. coli was found with production of non-useful enzymes in values from 5 up to 30 nmol. However, they were susceptible to herbal essential oils (HEO-oregano, thyme, sage, and coriander) with average inhibitory zone from 15 up to 27 mm in diameter. Tey were also (6) susceptible to postbiotic substance (Ent) 412 (activity up to 6400 AU/ml. Postbiotic substances represent one of novel approaches to fight with virulence factor possessing E. coli. Moreover, their combination with HEO increases their antimicrobial effect. These treatment conditions correspond with One Health Concept.

Keywords: 
;  ;  ;  ;  ;  

1. Introduction

In general, the prevalence of antibiotic-resistant bacteria is an increasing problem due to the possible transmission of resistant bacteria or their resistance genes between animals and humans via direct and/or indirect contact [1]. Antibiotic resistant Escherichia coli may constitute a reservoir of antibiotic-resistance determinants. The determinants can be spread to those bacteria which are pathogenic for animals and humans [1]. The biofilm-forming ability and so biofilm development represents also problem [2]. Although Gram-negative species Escherichia coli have been recognized to be a component of healthy intestinal microbiota [3], they can differ in their capacity to persist in the normal colonic microbiota. Resident strains may colonize an individual for months and years, while transient strains are found only once, or on a few occasions closely spaced in time in an individual intestine [3]. On the other side, diseases caused by some E. coli species are one of the most important diseases and they represent a public health risk [4,5]. E. coli synthesize a variety of adhesins which allow them to colonize, persist and/or cause disease. There are filaments called fimbriae that allow bacteria to adhere a variety of cells [6]. It enhances E. coli biofilm formation [7]. Curli regulatory gene (crl) is responsible for production of curli fibers in E. coli [6]. HlyA (α-hemolysin) is a toxin responsible for the strain pathogenicity [8]. The strains containing the eae gene (outer membrane protein-intimin) frequently cause diarrhea; and espA gene (superficial protein) as well. Therefore, it is very important to control and/or reduce growth of these type of E. coli strains.
Postbiotic substances and bacteriocins (to homogeneity or not purified antimicrobial substances of proteinaceous character with an inhibitory effect against more or less relative bacteria) represent one of these approaches [9]. Their inhibitory effect (e.g. Enterocin-like substances) was also presented in our several studies. Lauková et al. [10] reported effective treatment of contaminant strains Enterococcus faecalis (from raw goat milk) due to postbiotic active substances produced by autochthonous lactococci. Pogány Simonová et al. [11] reported reduction of fecal coliforms (p< 0.001) and pseudomonads (p< 0.05) in broiler rabbits after application of postbiotics, Ent M and Durancin ED26E/7. Postbiotic substance (PS-Ent) 412 is a thermo-stable antimicrobial proteinaceous substance produced by the horse strain Enterococcus faecium EF412 [12]. This strain is susceptible to antibiotics and it showed adhesion ability to human and canine mucus [13]. PS 412 was applied in horses with the following benefits noted: coliforms were significantly inhibited (p<0.001) after 3 weeks of PS 412 application; phagocytic activity was increased (69.0 ± 3.99 at day 21 to 67.89 ± 3.66 at start of experiment); biochemical parameters in blood were not negatively influenced (Lauková et al., unpublished data yet).
In addition, also herbal essential oils are known to have antimicrobial effect [14,15,16]. Herbal essential oils and their components as products from the secondary metabolism of plants have been known to have antimicrobial and antioxidant properties for a long time used in preservation, food and pharmaceutical industry [14]. E.g. carvacrol (2-methyl-5-(1-methylethyl)-phenol) is a major component of the oregano essential oil. It was reported to inhibit E. coli, L. monocytogenes, Salmonella Enterica, and Campylobacter jejuni [17]. Thymol (5-methyl-2-(1-methyl)-phenol) has been commercially used for hundred years [17]. Its essential oil has been shown to exhibit a range of biological activities, e.g. aflatoxin production inhibition. Its antimicrobial activity was also documented against E. coli, listeriae, campylobacters [17]. Sage (Salvia officinalis L.; family Labiatae) essential oil in combination with Enterocin M increased mucus production quantity in duodenum and jejunum (p<0.001, and p<0.01) in broiler rabbits after their 3 weeks application in comparison with control rabbits [18]. Moreover, Coriandrum sativum L. (Apiacae) essential oil has been reported to inhibit the growth of Gram-negative species such as E. coli, Yersinia enterocolitica, Enterobacter spp., Klebsiella pneumoniae, etc. [16]. Therefore, carvacrol, thyme, oregano. containing oils have attracted research attention for further application.
Having in mind this information, the aim of the study was to study if four selected essential oils (oregano, thyme, sage and coriander) and postbiotic substance PS (Ent) 412 can inhibit virulence factor genes possessing pig-derived E. coli to find another new tool for prevention and/or elimination of those type strains of E. coli.

2. Materials and Methods

2.1. Taxonomical Identification of Isolates

The isolates were selected from 26 rectal swabs and 9 samples from dead pigs obtained from eight pig farms from Vojvodina region in Serbia in the framework of co-operation with our colleague [19]. Sampling was provided according to the rules for Animals handling with acceptance of farmers and veterinarians and appropriate veterinary administration in Serbia. The colleagues from Serbia immersed the swabs into sterile saline solution (pH 7.5) and transported to the laboratory in cooling boxes at the same day [19]. The samples were inoculated onto Mac Conkey agar (Biokar Diagnostics, Allone, France), XLD agar (Biokar, France) and Trypticase soy agar (Biokar, France) enriched with 5% of defibrinated sheep blood [19]. Particular identification of grown colonies was performed phenotypically using biochemical testes (oxidase and catalase tests, indole, methyl red, urea and citrate) by colleagues in Serbia. After supplying identified strains into our laboratory (Laboratory of Animal Microbiology, Department of Animal Physiology, Centre of Biosciences of the Slovak Academy of Sciences in Košice, Slovakia), the strains were pre-inoculated using Trypticase soy broth (Difco, Sparks, MD, USA) and Mac Conkey agar (Difco, USA) and analyzed using MALDI-TOF mass spectrometry (Matrix-Assisted-Laser Desorption/Ionization Time of Fight Mass Spectrometry; Bruker Daltonics, San Jose, CA, USA).
The MALDI-TOF analysis was performed as previously described by Lauková et al. [20,21]. This method is based on protein detection “fingerprints” (Bruker Daltonics, Biotyper 2.2.) [20,21,22,23] performed using a Microflex MALDI-TOF mass spectrometer. Briefly, a solitary colony of each isolate from Trypticase soy agar (Difco) with 5% of defibrinated sheep blood was mixed with a matrix (α-cyano-hydroxycinnamic acid and trifluoroacetic acid). This suspension was spotted onto a MALDI plate and ionized with a nitrogen laser (wave length of 337 mm; frequency of 20 Hz). The evaluation score was assessed according to the MALDI Biotyper 3.0 (Bruker Daltonics, Billerica, MA, USA) identification database. The taxonomy of strains was classified as highly probable species identification (score range 2.300-3.000), secure genus identification/probable species identification (2.000-2.299), and on the basis of highly probable genus identification (1.700-1.999). The positive controls were involved in the identification database. Identical colonies evaluated using the score were excluded. Finally, 16 strains were used for the next analyses. The Microbank system (Pro-Lab Diagnostic, Richmond, BC, Canada) was used for the identified strains storage.

2.2. Virulence Factor Genes Detection of Pig-Derived Escherichia coli

The following virulence factor genes were screened: fimA (fimbriae), crl (curli regulatory gene), hlyA (hemolysin), eaeA (outer membrane protein-intimin), and espA (superficial protein). The primers used are summarized in Table 1. The single PCR was performed using Thermocycler Techgene KRD, Techne, the United Kingdom) and protocol for fimA gene detection reported previously Nowrouzian et al. [3]: an initial denaturation step at 94 °C for 3 min, followed by 30 cycles of DNA denaturation at 94 °C for one minute, primer annealing at 63 °C one min, a primer extension at 72 °C (one min) and a final extension step at 72 °C for 7 min. In case of hlyA gene, the PCR condition included an initial denaturation at 94 °C (2 min), then 30 cycles at 94 °C (one min), annealing at 58 °C for one min, primer extension at 72 °C (one min) and a final extension at 72 °C (7 min) [24]. The eaeA gene was determined under the PCR protocol including and initial denaturation at 94° C (one min), 30 cycles at 94 °C for 30 s, annealing at 55° C for 30 s, an extension at 72 °C (one min), and a final extension at 72 °C for 10 min [25]. The conditions 94 °C for 5 min, 40 cycles at 94 °C for 30 s, annealing at 50 °C (one min) and extension at 72 °C (one min) and at 72 °C (10 min) were used for espA gene detection [26]. In case of crl gene, an initializing denaturation was performed at 94 °C for 2 s, followed by 30 cycles at 55 °C for 3 s, an annealing at 55° C, an extension at 72° C for 15 s [6]. The amplifications were carried out in a single tube with a volume of 25 µL, utilizing Taq polymerase (0.2 µL, Promega, Madison, WI, USA) with 10 x buffer (2.5 µL), and MgCl2 (1.6 µL), primers (0.2 µL each, Lambda Life, Bratislava, Slovakia), deoxynucleotide triphosphate (dNTP, Promega, USA) and water (17.4 µL) mix. Specific gene products were analyzed using electrophoresis on 1.5% agarose gel (Sigma, Germany), 1x TAE (Tris-acetate-EDTA, Merck, Germany) gel at 70 V. The products were visualized with GelRed (Biotium Inc., Hayward, CA, USA) under UV light. The 100 bp ladder (Promega, Madison, WI) served as molecular weight standard to determine molecular weight of the products. Positive controls were E. coli Ec A/Zn/2021 and EcK212Tr (our strains).

2.3. Biofilm-Forming Ability Testing

Two methods were used for this testing. The qualitative method based on biofilm-forming ability using Congo red agar [27]. The components of this medium include TSbroth (Difco, MI, USA, 37 g/L) with 30 g/L pure agar, 36 g/L sucrose and Congo red dye (0.8 g/L, Merck, Germany). E. coli were inoculated on Congo red agar and incubated at 37 °C for 24 h. Biofilm-forming ability of E. coli was demonstrated by black colonies with a dry crystalline consistency. The non- biofilm-forming strains remained pink. The color was alsochecked after 48 h and 72 h placing plates at room temperature [28]. The quantitative microtiter plate assay [29] was also applied for biofilm testing. An individual colony of the E. coli strain grown on Trypticase soy agar overnight (TSA, Difco, Sparks, MD, USA) was transferred into 5 mL of Ringer solution (pH 7,0; Merck, Darmstadt,Germany) to reach 1.0 x 108 CFU/L. The, 100 µL of this suspension was transferred into 10 mL of Trypticase soy broth/infusion (BHI). A 200 µL of their dilution was inoculated in microtiter plate wells (Greiner ELISA 12 Well Strips, 350 µL (Greiner ELISA 12 Well Strips flat bottom, Frickenhausen GmbH, Germany) as previously reported by Lauková et al. [30]. After incubation at 37 °C overnight, the biofilm forming in the microtiter wells was washed twice with 200 µL of deionized water and dried at 25 °C for half hour. The next step was to stain the remaining bacteria for 30 min at 25 °C with 200 µL of 0.1 % (w/v) crystal violet in deionized water. The second drying of plates was provided (half hour at room temperature). The dye bound to the adhered biofilm was extracted using 200 µL of 95% ethanol and stirred. A 150 µl aliquot was again transferred to a microplate well and absorbance A570 (Synergy TM4 MALDI mode Microplate reader, Biotek, Seattle, WA, USA) was measured. Two indep endent analyses with 12 replicates were performed for each E. coli strain. A sterile BHI was included in each test as a negative control. The positive control was the strain Streptococc us equi subsp. zooepidemicus CCM 7316 (kindly provided by Dr. Eva Styková from the University of Veterinary Medicine and Pharmacy in Košice, Slovakia). The biofilm-forming ability of the strains E. coli was evaluated as reported Chaieb et al. [29]. The following classification used: highly-positive (A570 ≥ 1, low grade positive (0.1 ≤ A570 < 1.0, or negative (A570 < 1.0).

2.4. Antibiotic Disc Diffusion Test and Enzyme Activity Detection

To test susceptibility to antibiotics of E. coli, agar disc diffusion method [31] was applied. The antibiotics (13) used were supplied by Oxoid Ltd. (Basingstoke, UK) as follows:clindamycin (DA-2 µg), penicillin (P-10 IU), ampicillin (AMP-10 µg), gentamicin (CM-10 µg), erythromycin (E-15 µg), azithromycin (AZM-15 µg), amikacin (AK-30 µg), chloramphenicol (C- 30 µg), tetracycline (T-30 µg), mezocillin (MEZ-75 µg), ticarcillin (TIC-75 µg), carbenicill in (Car-100 µg), and piperacillin (PRL-100 µg). Briefly, broth cultures (in Trypticase soybroth, Difco) of tested strains (100 µL) were spread onto Mueller-Hinton agar (Bio-Rad, Bratislava, Slovakia) as well as on Trypticase soy agar (Difco). When antibiotic discs were applied on the agar surface, the agar plates were incubated at 37 °C for 18 h. After incubationthe inhibitory zones were evaluated and expressed in mm. They were assessed according to the guidelines of the Clinical and Laboratory Standards Institute [21]. The API ZYM panel (Bio Merieux, Marcy lEtoile, France) was used for the enzyme detection according to the manufacturers instructions as previously reported by Lauková et al. [32]. Briefly, a volume of 65 µL of McFarland standard inoculum was transferred into each well of the tested panel plate. After incubation of the panel plate at 37 °C for 4 h in incubator, reagents Zym A and Zym B were added in each one well. Enzyme activity was evaluated based on color intensity values (0-5) and their relevant values in nanomoles (nmol). They were assigned for each reaction according to the color chart supplied with the kit. The enzymes tested included in panel were as follows: alkaline phosphatase, esterase (C4), esteraselipase (C8), lipase (C14), leucine arylamidase, valine arylamidase, cystine arylamidase, tryps in, α-chymotrypsin, acid phosphatase, Naphtol-AS-BI-phosphohydrolase, α-galactosidase, β-galactosidase, β-glucuronidase, α-glucosidase, β-glucosidae, N-acetyl-β-glucosaminidase,α-mannosidase, and α-fucosidase.

2.5. Susceptibility to Herbal Essential Oils of E. coli

The essential oils used were obtained from Calendula a.s. Nová Ľubovňa (Slovakia).In testing were included: Salviae aetheroleum from sage (Salvia officinalis L.; family Labiatae) contained cineol 15.0 ± 10.0.5%), thujon (24.0 ± 1.0%), and borneol 18.0 ± 1.0). Oregano aetheroleum from Origanum vulgare L. (Lamiacae) contained 55.0 ± 3.0 % of carvacrol. Coriandri aet eheroleum from Coriandrum sativum L. (Apiacae) contained 53. 0 ± 2.0 % of the main component linalool. Thymi aetheroeum from thyme (Thymus vulgari L., Lamiacae) contained 40.0 ± 3.0% of p-cymene, and 32. 0 ± 2.0 % of thymol. The components of these oils were measured using gas chromatography. The agar spot test [33] was used to test essential oils effect against the strains E. coli. For this purpose, E. coli were grown in TSY (overnight). The volume 4 mL of soft agar (w/v 0.7 %) was inoculated with 200 µL of each tested strain and TSY (w/v, 1.5%) was overlaid with this mixture. Then 10 µL of each the essential oil (EO) was dropped on the plate surface. The plates were incubated at 37 °C and after 4 h first check was done. The second check was provided after overnight incubation. The susceptibility of E. coli was evaluated as an average size of inhibitory zone (in mm). Escherichia coli ATCC 2592 was positive control.

2.6. Postbiotic Substance (Enterocin-like) 412 Preparation and Susceptibility to PS 412 of Pig-Derived E. coli

The PS 412 was prepared following the procedure according to Mareková et al. [34].
The volume 200 mL of MRS broth (de Man-Rogosa-Sharpe) (pH 7, Merck, Germany) was inoculated with 14 h-18 h culture of Enterococcus faecium EF412 (0.1% inoculum) at 37 °C. The culture was centrifuged (10 000 x g) for 30 min. The supernatant was adjusted to have pH 5.5 and precipitated with ammonium sulfate (40% saturation) in the plastic jar by stirring at 4 °C for 1 h and/or more regarding the precipitation process. Then followed second centrifugation (10 000 x g) for 30 min. The pellets from centrifuging tubes were re-suspended in minimal volume of 10 mM phosphate buffer (pH 6.5). The inhibitory activity (volume 2.0 mL) of precipitate (postbiotic substance) was tested against E. avium EA5 (the principal indicator, our strain) using agar spot test [33] and expressed in AU/mL after dilution in the phosphate buffer. The activity reached 51 200 AU/ml. Then E. coli strains were treated with PS as formerly indicated.

3. Results

3.1. Strains Taxonomy Using MALDI-TOF Mass Spectrometry, Virulence Factor Genes and Biofilm-Forming Ability of Escherichia coli

Identified E. coli strains with evaluated score are summarized in Table 2. Altogether 16 strains were taxonomically allotted and confirmed to the species Escherichia coli. Fourteen strains (87.5%) reached score in range 2.000-2.299. It responds with secure genus identification/probable species identification. The strains E. coli Ec3419/4 and Ec3298/4 were evaluated with range score 1.700-1.999 meaning highly probable genus identification (Table 2). The strain Ec3419/1 reached the highest score (2.238).
Six out of 16 E. coli were fimA gene absent; however, fimA genes were found in 10 strains (62.5%, Table 2). Crl gene was detected in 14 strains (87.5 %); only two strains (Ec7676/4 and Ec3477/1) were crl gene absent. The E. coli tested were mostly hlyA, eae and espA genes absent (11 strains in each, Table 2). These genes were detected altogether in 5 strains. E. coli Ec3419/2 possessed all 5 analyzed genes. The strain Ec3298/1 possessed four genes (espA gene was not detected). Mostly three genes were found in tested strains. In the strain Ec3419/4 was present only crl gene. The strains Ec7676/4 and Ec3477/1 were virulence factor genes absent.
Using Congo red agar to test biofilm-forming ability in E. coli, this ability was found in five strains (31.2%, Table 2); dubious reaction was noted in three strains, and 11 strains did not show biofilm-forming using Congo red agar. In dubious reaction, negative production was confirmed using the quantitative plate assay. The values less than 0.1 were measured (Table 2) almost in all tested strains, even in those with positive reaction on Congo red agar. In three negative strains tested using Congo red agar, no biofilm-forming ability was also confirmed by the plate agar assay (Table 2). In general, measurements ranged from 0.006 up to 0.050.

3.3. Antibiotic Disc Diffusion Test and Enzyme Activity Detection

The strains E. coli were resistant to clindamycin and penicillin. Oppositelly, they were all susceptible to amikacin (AK30) with the inhibitory zones up to 13 mm. Elevenstrains out of 16 (Table 3, 68.8%) were resistant to chloramphenicol (C30), five strains were susceptible to this antibiotic (Table 3). Even, 13 strains (81.3%) were resistant to tetracycline (T30), 12 strains (75%) were found to have resistance to ampicillin (AMP10). Surprisingly, 8 strains were gentamicin (CM10) resistant and 8 strains were CM10 susceptible. Fifteen E. coli (15) were resistant to erythromycin (E15, 93.8%). To azithromycin (AZM15) were E. coli mostly resistant (11 strains, 68.8%) as well as to mezlocillin (MEZ75,) 10 strains of E. coli (62.5%). The same amount of E. coli (10 strains, 62.5 %) were resistant to ticarcillin (TIC75, Table 3). The tested E. coli (16) were also mostly resistant to Car100 carbenicillin- 15 out of 16 strains (93.8 %). Opposite condition was noted in case of pipe-racillin (PRL100) when almost 12 strains were susceptible and six strains were resistant this antibiotic. In general, the strains were mostly resistant to antibiotics tested. Each one tested E. coli was found to produce enzymes but with various values (Table 4). The values of esterase (C4), lipase (C14), leucin-arylamidase, valin- arylamidase, cystin- arylamidase, trypsin, α-glucosidase, β-glucosidase, α- mannosidase, and α-fucosidase reached 5 nmol in each tested E. coli (Table 4). Higher values (10-20 nmol) were measured for alkalic phosphatase. Regarding esterase-lipase, and α-galactosidase, the most strains reached 5 nmol, except Ec3152 and Ec3419/6 with value 10 nmol and Ec3298/4 as well. The enzyme α -chymotrypsin was also produced by the tested E. coli in amount 5 nmol except Ec3419/6 (10 nmol). The values for acidic phosphatase and Naftol-AS-BI-phosphohydrolase were almost the same; the values 10, 20 nmol dominated, except in the strain Ec7612/4 for acidic phosphatase (30 nmol) and for the strains Ec3298/3 3298/4 in case of Naftol-AS-BI-phosphohydrolase (30 nmol). The volumes 5 nmol were found for α-galactosidase, except Ec3298/4 (10 nmol. For β-galactosidase, the values 5 nmol up to strains 10 nmol were noted. In case of N-acetyl-β-glucosaminidase only Ec7612/4 reached 30 nmol, the others produced 5 nmol of this enzyme.

3.4. Susceptibility to Herbal Essential Oils and Postbiotic Substance of E. coli

All tested strains E. coli were susceptible to oregano, thyme, sage, and coriander as well (Table 5). The average value of inhibitory zone after E. coli treatment with oregano reached 27.0 ± 0.0 mm. E. coli Ec3419/1 was the least susceptible to oregano with an inhibitory zone size 16 mm. The most susceptible was E. coli Ec3276 with an inhibitory zone size 36 mm. Treatment with oregano lead to the broadest inhibitory zones (Table 5). As second essential oil to which E. coli were susceptible was thyme. There average inhibitory zone size measured 18 mm. The strain Ec3419/2 could be supposed resistant because small inhibitory zone (5 mm). The broadest zone 25 mm reached Ec3419/3. In case of sage and coriander, the average inhibitory zones reached 15 mm. The strains Ec3298/1, Ec3298/2, 3298/3, 3298/4 belonged to the most susceptible to essential oils and also to PS 412 (Table 5) with inhibitory activity from 100 up to 6 400 AU/ml. Ec3298/4 was the most susceptible to PS 412 (6 400 AU/ml). Ten strains were not inhibited using PS 412; however, their growth was inhibited using herbal essential oils.

4. Discussion

The first important step to work with selected microbiota is their identification. In this study after first phenotyping, MALDI-TOF MS was applied. It is an accurate method for laboratory use because of simple approach designed for protein detection. It represents a reliable technology for the precise identification of cultured microbiota [20]. This method looks as sufficient identification tool regarding the species E. coli reaching high score. It was also successfully applied in identification of fecal E. coli from ostriches [35]. As it is known, the species E. coli belongs to the family Enterobacteriacae, to order Enterobacterales, to class Gammaproteobacteria and phylum Pseudomonata (Proteobacteria). As formerly mentioned, E. coli is a common commensal bacterial species of animals and humans that may become a troublesome pathogen causing diseases [36].
Regarding the virulence factors, the curli gene crl is mostly present in avian E. coli [6]. Eae protein (intimin) contribute to cells microvilli damaging. It is a key virulence factor associated with diarrheal disease [36]. Intimin is critical for the bacterial ability to adhere to intestinal cells. The strains containing the eae gene are responsible for causing diarrhea [37]. In our strains 5 were found possessing eaeA gene. The fimA gene represents a crucial virulence factor in E. coli for adhesion to host cells and colonization of tissue. It is adhesin helping bacteria to attach to host tissues, allowing them to colonize and establish infections [3]. The espA gene encodes protein essential for activating epithelial signal transduction, intimate contact and formation of attaching and effacing lesions, processes which are central to pathogenesis [26]. HlyA gene is a member of the RTX toxin family. It is believed that the persistence of α-hemolytic E. coli strains in the host may be a reason for the emergence of intestinal and/or extra-intestinal infections [38]. In this study, mostly crl gene was detected.
Here studied E. coli shown multi-drug resistance which can be problem in Serbian pig farming. Transfer of microbial resistance genes is a problem which lead to permanent control of antimicrobial resistance. As Stojanov et al. [19] previously reported, 100% resistance to penicillin of E. coli from piglets at grower stage, we also found the same results in pigs-derived E. coli from Vojvodina region. Roderová et al. [36] reported 97% resistance to ampicillin and 96% resistance to PRL of E. coli from hospitalized patients. It is in opposite to by us noted 100% susceptibility to PRL. Gentamicin represents an older member of the aminoglycosides to which half of our tested E. coli was resistant and half strains (8) susceptible. Similarly, Kerluku et al. [39] observed CM resistance in E. coli with low resistance level from cattle and sheep. Similarly, as by Kerluku et al. [39], also in our strains moderate resistance toward AZM was noted.
The tested E. coli produce damaging enzymes although not in huge amount. The production of enzymes such as α-chymotrypsin, β-glucuronidase or alkalic phosphatase contribute to their pathogenic character. E. g. alkalic phosphatase serves as a marker in case of hepatitis diagnosis. The enzyme β-glucuronidase as microbial source can play role in disease related mainly with estrogen metabolism [40].
Naturally occurring substances were found effective to inhibit/reduce E. coli infections [14,15]. Among those natural belongs also lantibiotic bacteriocin nisin which was effectively used in combination with cinnamaldehyde and EDTA to control swine origin E. coli [41]. In our case, postbiotic substance, Enterocin-like 412 inhibited the growth of 6 out of 16 strains. It is interesting that in experimental in vivo application using various animals, but most frequently in broiler rabbits, poultry and/or horses, reduction of E. coli was noted and beneficial influence using this and also other Enterocins, Enterocin-like substance and/or postbiotics [42]. There was shown beneficial preventive use of Ent7420 in improving the growth and immunity of rabbits and also protective effect against infection caused by methicillin-resistant staphylococci. Underlining postbiotic substances effectivity, the completely new achievements were reported by Petrová et al. [43]. The direct effect of Enterocins (Ent M and Duranci ED26E/7) on Trichinella spiralis fecundicity was documented by in vitro test. There Durancin-like showed a reducing effect (40-60%). The reducing activity of T. spiralis infection induced by Ent M was also noted [43]. Moreover, Al Atya et al. [44] reported inhibition of swine-derived E. coli grown in both planktonic and biofilm cultures using LAB-bacteriocins (nisin + Enterocin DD14) in combination with colistin. The author even outlines advantages of antibiotic-LAB bacteriocin combinations and merits further development as potential novel treatments for E. coli infections. Here tested E. coli did not show biofilm-forming ability. Postbiotic 412 use approach was supported by the use of HEO. In some experiments [15] authors also indicated that dietary administration of a combination of thyme and oregano essential oils in appropriate concentrations can reduce the production of pro-inflammatory cytokines and attenuate the degree of colonic tissue injury and ameliorate colitis in mice. In our case, the strains Ec3298/1, Ec3298/2, 3298/3, 3298/4 possessing virulence factor genes were belonged to the most susceptible to essential oils and also to PS 412. Therefore, this study contributes to indicate a possible strategy for protection and/or elimination of non-requested microbiota, such virulence factor genes containing E. coli belong. Although it is necessary to continue in this testing, it is indication to solve problem with multidrug resistant E. coli also on farms in Vojvodina region.

5. Conclusions

The pig-derived Escherichia coli with virulence factor genes, multi-drug resistance and production of damaging enzymes were susceptible to essential herbal oils (HEO: oregano, sage, thyme and coriander). Moreover, 6 strains out of 16 strains were susceptible to postbiotic (Enterocin-like) substance 412. These results are contribution showing another new tool such as postbiotic substance in combination with HEO to reach the final elimination of virulence factor genes possessing E. coli. To control those strains is requested because of One Health concept.

Author Contributions

Conceptualization, A.L.; methodology, A.L..; I.S.; J.P.R.; J.Š.; V.F.; validation, I.S.; A.L.; formal analysis, M.P.S.; J.P.R.; investigation, A.L.; J.Š.; V.F.; I.S.; J.P.R.; resources, I.S.; J.P.R.; data curation, A.L.; I.S.; writing—original draft preparation, A.L.; writing—review and editing, A.L.; project administration, A.L.; M.P.S.; J.P. R.; funding acquisition, M.P.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the bilateral project between the Republic of Serbia and the Slovak Republic with no. 337-00-107/2019-09/14 in Serbia and SK-SRB-18-0001 in Slovakia entitled “Bacteriocins, a safe way to inhibit antibiotic resistant bacteria from pigs for healthy farming” supported by the Ministry of Education and Technological Development of the Republic Serbia and by the APVV agency of Slovak Republic. It was also partially supported by the VEGA project no. 2/0009/25 by the Slovak Scientific Agency.

Institutional Review Board Statement

Ethical review and approval were waived for this study because the phenotypically identified strains were supplied for next study by our colleagues from Serbia. However, they have national approval in the framework of the project no. 337-00-107/2019-09/14 by the Republic of Serbia.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data will be provided by the corresponding author upon request.

Acknowledgments

GenAI was not used in preparing of this manuscript, either in specific text nor in language. The authors have reviewed and edited the output and take full responsibility for the content of this publication.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the decision to publish the results.

References

  1. Karahutová, L.; Mandelík, R.; Bujňáková, D. Antibiotic resistant and biofilm-associated Escherichia coli isolates from diarrheic and healthy dogs. Microorganisms 2021, 9, 1334. [Google Scholar] [CrossRef]
  2. Sharma, D.; Misba, L.; Khan, A.U. Antibiotics versus biofilm: An emerging battleground in microbial communities. Antimicrob. Resist. Infect. Control 2019, 8, 76. [Google Scholar] [CrossRef] [PubMed]
  3. Nowrouzian, F.; Adleberth, I.; World, A.E. P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli. Epidemiol. Infect. 2001, 126, 11–18. [Google Scholar] [CrossRef] [PubMed]
  4. Barbosa, L.J.; Ribeiro, L.F.; Lavezzo, L.F.; Barbosa, M.M.C.; Rossi, G.A.M.; do Amaral, L.A. Detection of pathogenic Escherichia coli and microbiological quality of chilled shrimp sold in street. Lett. Appl. Microbiol. 2016, 62, 372–378. [Google Scholar] [CrossRef] [PubMed]
  5. Rose, M. Intestinal infections caused by Escherichia coli. J. Probiot. Health 2022, 10, 300. [Google Scholar]
  6. Maurer, J.J.; Brown, T.P.; Steffans, W.L.; Thayer, S.G. The occurrence of ambient temperature-regulated adhesins, curli, and the temperature-sensitive hemagglutinin Tsh among avian Escherichia coli. Avian Dis. 1998, 42, 106–118. [Google Scholar] [CrossRef]
  7. Qingguo, L.; Jiaqing, Z.; Na, L.; Wenjun, S.; Bin, Y.; Huanqing, N.; Dong, L.; Pingkai, Q.; Hanjie, Y.; Yong, Ch.; Gulin, Z.; Tianpeng, Ch. Type I fimbriae subunit fimA enhances Escherichia coli biofilm formation but affects L-threonine carbon distribution. Front. Bioeng. Biotechnol. 2022, 10, 904636. [Google Scholar] [CrossRef]
  8. Čurová, K.; Kmeťová, M.; Vargová, R.; Lovayová, V.; Siegfried, L. Toxins of extraintestinal Escherichia coli isolated from blood culture. Clin. Microbiol. 2014, 3, 5. [Google Scholar] [CrossRef]
  9. Chikindas, M.L.; Sichel, L.S.; Popov, I.V.; Tagg, J.R.; Lu, X.; Mitrokhin, O.V.; Todorov, S.D. Postbiotics: what are they? Ben. Microbes 2025, 1–8. [Google Scholar]
  10. Lauková, A.; Bino, E.; Zábolyová, N.; Maďar, M.; Pogány Simonová, M. The strains Enterococcus faecalis as contaminants of raw goat milk and their treatment with postbiotic active substances produced by autochthonous lactococci. Processes 2025, 13, 3552. [Google Scholar] [CrossRef]
  11. Pogány Simonová, M.; Lauková, A.; Chrastinová, Ľ.; Kandričáková, A.; Ščerbová, J.; Strompfová, V.; Miltko, R.; Belzecki, G. Enterocins as novel feed additives in rabbit diet: Enterocin M and Durancin Ent ED26E/7, their combination, and effects on microbiota, caecal fermentation, and enzymatic activity. Prob. Antimicrob. Prot. 2021, 13, 1433–1442. [Google Scholar] [CrossRef] [PubMed]
  12. Lauková, A.; Micenková, L.; Kubašová, I.; Bino, E.; Kandričáková, A.; Plachá, I.; Štrkolcová, G.; Gálik, B.; Kováčik, A.; Halo, M.; Pogány Simonová, M. Microbiota, phagocytic activity, biochemical parameters and parasite control in horses with application of autochthonous, bacteriocin-producing, probiotic strain Enterococcus faecium EF412. Prob. Antimicrob. Prot. 2023, 15, 139–148. [Google Scholar] [CrossRef] [PubMed]
  13. Lauková, A.; Simonová, M.; Strompfová, V.; Štyriak, I.; Ouwehand, A.C.; Várady, M. Potential of enterococci isolated from horses. Anaerobe 2008, 14, 234–236. [Google Scholar] [CrossRef] [PubMed]
  14. Fabian, D.; Sabol, M.; Domaracká, K.; Bujňáková, D. Essential oils-their antimicrobial activity against Escherichia coli and effect on intestinal cell viability. Toxicol. in vitro 2006, 1435–1445. [Google Scholar] [CrossRef]
  15. Bukovská, A.; Číkoš, Š.; Juhás, Š.; Iľková, G.; Rehák, P.; Koppel, J. Effects of a combination of thyme and oregano essential oils on TNBS-Induced colitis in mice. Med. Inflam. 2007, 23296, 9 pages. [Google Scholar] [CrossRef]
  16. Shyamapada, M.; Manisha, M. Coriander (Coriandrum sativum L.) essential oil:Chemistry and biological activity. Asian Pac. J. Trop. Biomed. 2015, 5, 421–428. Available online: http://creativecommons.org/license/by-nc-nd/4/0/.
  17. Rodrigues, M.R.; Krause, L.C.; Caramao, E.B.; dos Santos, J.G.; Dariva, C.; de Oliveira, J.V. Chemical composition and extraction yield of the extract of Origanum vulgare obtained from sub-and supercritical CO2. J. Agri. Food Chem. 2004, 52, 3042–3047. [Google Scholar] [CrossRef]
  18. Szabóová, R.; Lauková, A.; Herich, R.; Tarabová, L.; Chrastinová, Ľ.; Faixová, Z.; Makoová, Z.; Piešová, E. The effect of dietary supplementation of sage plant extract and Enterocin M on the mucus in the small intestine and caecum of rabbits. Polish J. Vet. Sci. 2021, 24, 23–28. [Google Scholar] [CrossRef]
  19. Stojanov, I.; Prodanov-Radulovič, J.; Lauková, A.; Grešáková, Ľ.; Petrovič, J.; Ratajac, R.; Pušič, I. Clinical isolates of E. coli in pigs- antimicrobial resistance and perspectives to optimize antibiotic administration. Arhiv Vet. Med. 2020, 13, 17–27. [Google Scholar] [CrossRef]
  20. Lauková, A.; Kubašová, I.; Kandričáková, A.; Strompfová, V.; Žitňan, R.; Pogány Simonová, M. Relation to enterocins of variable Aeromonas species isolated from trout of Slovakian aquatic sources detected by MALDI-TOF mass spectrometry. Folia Microbiol. 2018, 63, 749–755. [Google Scholar] [CrossRef]
  21. Lauková, A.; Kandričáková, A.; Ščerbová, J.; Pogány Simonová, M.; Žitňan, R. Gram-negative microbiota derived from trout fished in Slovakian water sources and their relationship to postbiotics. Pathogens 2025, 14, 644. [Google Scholar] [CrossRef] [PubMed]
  22. Umer, A.A. review on MALDI TOF MS: Modern disease diagnosis approaches in microbiology and its mechanisms. J. Microbiol. Mod. Tech. 2023, 7, 102. [Google Scholar]
  23. Bruker Daltonics.Maldi Biotyper CA system; Software for Microorganisms Identification and Classification User Manual; Bruker Daltonics, Inc.:Billerica, MA, USA, 2008.
  24. Yamamoto, S.; Terai, A.; Yuri, K.; Kurazano, H.; Takeda, Y.; Yoshida, O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol. Med. Microbiol. 1995, 12, 85–90. [Google Scholar] [CrossRef] [PubMed]
  25. Donnenberg, M.S.; Yu, J.; Kaper, J.D. A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J. Bacterial 1993, 175, 4670–4680. [Google Scholar] [CrossRef]
  26. Kenny, B.; Lai, L.C.; Finlay, B.B.; Donnenberg, M.S. EspA, a protein secreted by enteropathogenic Escherichia coli is required to include signals in epithelial cells. Mol. Microbiol. 1996, 20, 313–323. [Google Scholar] [CrossRef]
  27. Freeman, D.J.; Falkiner, F.R.; Keane, C.T. New method for detecting slime production by coagulase-negative staphylococci. J. Clin. Pathol. 1989, 42, 872–874. [Google Scholar] [CrossRef]
  28. Bino, E.; Kandričáková, A.; Lauková, A. Biofilm formation in coagulase-negative staphylococci from various animals. Eur. J. Appl. Sci. 2024, 12, 317–323. [Google Scholar] [CrossRef]
  29. Chaieb, K.; Chehab, O.; Zmantar, T.; Rouabhia, M.; Mahdouani, K.; Bakrouf, A. In vitro effect of pH and ethanol on biofilm formation by clinically -postive Staphylococcus epidermidis strains. Ann. Microbiol. 2007, 57, 431–437. [Google Scholar] [CrossRef]
  30. Lauková, A.; Focková, V.; Maďar, M.; Miltko, R.; Pogány Simonová, M. Susceptibility to postbiotic substances-Enterocins of the strains Enterococcus thailandicus from beavers (Castor fiber). Pathogens 2025, 14, 269. [Google Scholar] [CrossRef]
  31. Lewis, J.S.; Weinstein, M.P.; Bobenchik, A.M.; Campeu, S.K.; Cullen, S.K.; Galas, M.F.; Gold, H.; Humphries, R.M.; Kirn, T.J.; Limbago, B.; et al. Clinical and Laboratory Standards Institute (CLSI); Performance Standards for Antimicrobial Susceptibility testing. In Clinical and Laboratory Institute, 32nd ed.; Pitsburgh, PA, USA, 2022; ISBN 978-1-68440-135-2i. [Google Scholar]
  32. Lauková, A.; Styková, E.; Focková, V.; Trosianczyk, A.; Maďar, M. Int. J. Equine Sci. 2024, 3, 51–57. Available online: https://rasayely-journlas.com/index.php/ijes. [CrossRef]
  33. De Vuyst, L.; Callewaert, R.; Pot, B. Characterization of antagonistic activity of Lactobacillus amylovorus DCE471 and large scale isolation of its bacteriocin amylovorin L471. Syst. Appl. Microbiol. 1996, 19, 9–20. [Google Scholar] [CrossRef]
  34. Mareková, M.; Lauková, A.; Skaugen, M.; Nes, I. Isolation and characterization of a new bacteriocin termed enterocin M, produced by environmental isolate Enterococcus faecium AL41. J. Ind. Microbiol. Biotechnol. 2007, 34, 533–537. [Google Scholar] [CrossRef] [PubMed]
  35. Ščerbová, J.; Lauková, A. Escherichia coli strains from ostriches and their sensitivity to antimicrobial substances. Polish J.Vet. Sci. 2016, 19, 415–423. [Google Scholar] [CrossRef] [PubMed]
  36. Roderová, M; Halová, D.; Papousek, I.; Dolejská, M.; Mararikova, M.; Hanulíik, V.; Pudová, V.; Broz, P.; Htoutou-Sedláková, M.; Sauer, P.; Bardon, J.; Cizek, A.; Kolar, M.; Lietrák, I. Characteristics of quinolone resistance in Escherichia coli isolates from humans, animals, and the environment in the Czech Republic. Front. Microbiol. 2017, 7, 2147. [Google Scholar] [CrossRef]
  37. Kmeť, V.; Bujňáková, D. Antimicrobial resistance Escherichia coli isolated from calves. J.Microbiol. Biotechnol. Food Sci. 2018, 7, 412–415. [Google Scholar] [CrossRef]
  38. Bírošová, E.; Siegfried, L.; Kmeťová, M.; Makara, A.; Ostró, A.; gresová, A.; Urdzík, P.; Liptáková, A.; Molokácsová, M.; Bártl, R.; Valanský, L. Detection of virulence factors in α-hemolytic Escherichia coli strains isolated from various clinical materials. Clin. Microbiol. Infect. 2004, 10, 569–573. [Google Scholar] [CrossRef]
  39. Kerluku, M.; Manoska- Ratkova, M; Prodanov, M.; Sojanowska-Dimzoska, B.; Hajrulai-Musliu, Z.; Jankuloski, D.; Blagoevska, K. Phenotypic and Genotypic analysis of Antimicrobial resistance of commensal Escherichia coli from dairy cow feces. Processes 2023, 11, 1929. [Google Scholar] [CrossRef]
  40. Hu, S.; Ding, Q.; Zhang, W.; Kang, M.; Ma, J.; Zhao, L. Gut microbial β-glucuronidase: a vital regulator in female estrogen. Gut Microbes 2023, 15, 2236749. [Google Scholar] [CrossRef]
  41. Field, D.; Baghou, I.; Marea, M.C.; Gardiner, G.E.; Ross, R.P.; Hill, C. Nisin in combination with cinnamaldehyde and EDTA to control growth of Escherichia coli strains of swine origin. Antibiotics 2017, 6, 35. [Google Scholar] [CrossRef]
  42. Pogány Simonová, M.; Chrastinová, Ľ.; Ščerbová, J.; Tokarčíková, K.; Grešáková, Ľ.; Žitňan, R.; Plachá, I.; Lauková, A. Front Vet. Sci. 2025, 12, 1660371. [CrossRef]
  43. Petrová, M.; Hurníková, Z.; Lauková, A.; Dvorožňáková, E. Antiparasitic activity of Enterocin M and Durancin -like from beneficial enterococci in mice experimentally infected with Trichinella spiralis. Microorganisms 2024, 12, 923. [Google Scholar] [CrossRef]
  44. Al Ataya, A.K.; Abriouel, H.; Kempf, I.; Jouy, E.; Auclair, E.; Vacheé, A.; Drider, D. Effects of colistin and bacteriocins combinations on the in vitro growth of Escherichia coli strains from swine origin. Prob. Antimicrob. Prot. 2016, 8, 183–190. [Google Scholar] [CrossRef]
Table 1. Oligonucleotide primer pairs to detect virulence factor genes in Escherichia coli strains.
Table 1. Oligonucleotide primer pairs to detect virulence factor genes in Escherichia coli strains.
Gene Oligonucleotide primer pairs Size of PCR product (bp) Reference
crl (curli regulatory gene), M571, M570 F:5-TTTCGATTGTCTGGCTGTATG-3
250 [6]
R:5-CTTCAGATTCAGCGTCGTC-3
eaeA (outer membrane protein-intimin,
non-fimbrial adhesin), eaeA 1, eaeA 2
F:5-CTGAACGGCGATTACGCGAA-3
917 [25]
R:5-CCAGACGATACGATCCAG-3
espA (protein secreted by enteropathogenic E. coli), espA1, espA2
F:5-GCGAGTACTTCGACATC-3
579 [26]
R:5-TTATTTACCAAGGGATAT-3
hlyA (α-hemolysin), hly1, hly2 F:5-GTCTGCAAAGCAATCCGCTGCAAATAAA-3
1177 [24]
R:5-CTGTGTCCACGAGTTGGTTGATTAG-3
fimA (fimbrial adhesin), fimA 1, fimA 2 F:5-ACGTTTCTGTGGCTCGACGCATCT-3
R:5-ACGTCCCTGAACCTGGGTAGGTTA-3
721 [3]
Table 2. The MALDI-TOF evaluating score, virulence factor genes and biofilm -forming ability of E. coli
Table 2. The MALDI-TOF evaluating score, virulence factor genes and biofilm -forming ability of E. coli
Strain MALDI-TOF fimA crl hlyA eaeA espA Congo/72 h Biofilm ± SD
Ec3298/1 2.067 + + + + - - 0.011 ± 0.009
Ec3298/2 2.127 - + - + + ± 0.006 ± 0.002
Ec3298/3 2.209 - + - + + - 0.005 ± 0.003
Ec3298/4 1.897 + + - - - + 0.050 ± 0.01
Ec3098/1 2.081 + + + - - + 0.007 ± 0.003
Ec3098/2 2.265 - + - + + - -
Ec3152 2.135 + + + - - - -
Ec3276 2.222 + + + - - - 0.027 ± 0.02
Ec3419/1 2.238 + + - - - - -
Ec3419/2 2.197 + + + + + ± 0.013 ± 0.004
Ec3419/3 1.988 + + - - - ± 0.025 ± 0.004
Ec3419/4 2.216 - + - - - - 0.013 ± 0.003
Ec3419/6 2.213 + + - - - + 0.018 ± 0.005
Ec3717/1 2.016 + + - - + + 0.015 ± 0.006
Ec7676/4 2.060 - - - - - + 0.048 ± 0.012
Ec3477/1 2.204 - - - - - - 0.039 ± 0.014
Virulence factor genes: fimA (fimbriae), crl (curli regulatory factor), hlyA (hemolysin), eaeA (outer membrane protein-intimin), espA (superficial protein). Growth of E. coli strains on Congo red agar (biofilm formation); + means positive reaction; - means negative reaction; ± means dubious reaction;.
Table 3. Antibiotic profile of tested E. coli.
Table 3. Antibiotic profile of tested E. coli.
Strain C30 T30 Amp10 CM10 E15 AZM15 AK30 Mez75 Tic75 Car100 Prl100
Ec3298/1 R R R +14 R R +12 R R R +10
Ec3298/2 +22 R R +12 R +11 +10 R R R +11
Ec3298/3 +20 R R +11 R +10 +10 R R R +10
Ec3298/4 R R R R R +10 +11 R R R R
Ec3098/1 +20 R R +11 R R +12 R R R +13
Ec3098/2 R R R R R R +12 R R R R
Ec3152 +20 R R +11 R +10 +10 R R R +10
Ec3276 R +12 R +11 +13 +10 +11 +10 +10 R +10
Ec3419/1 R R +15 R R +9 +10 +15 +15 R +9
Ec3419/2 R R R +10 R R +10 R R R +12
Ec3419/3 +23 +17 R +11 R +10 +10 R R R R
Ec3419/4 R R +15 R R R +10 +13 +14 R +16
Ec3419/6 R R R R R +10 +13 +15 +15 +10 +20
Ec7162/2 R +8 +17 R R +8 +10 +10 +11 R +17
Ec7612/4 R R +12 R R R +10 +10 +10 R +10
Ec3477/1 R R R R R R +10 R R R R
C30, chloramphenicol (30 µg); T30, tetracycline (30 µg); AMP10, ampicillin (10 µg); CM10, gentamicin (10 IU); E15, erythromycin (15 µg); AZM15, azithromycin (15 µg); AK30, amikacin (30 µg), MEZ75, mezlocillin (75 µg) TIC75, ticarcillin (75 µg); Car100, carbenicillin, (100 µg); PRL100, piperacillin (100 µg); R-resistant; + (no.) means the inhibitory zone size in mm; The strains E. coli were resistant to clindamycin and penicillin.
Table 4. Enzyme production by tested E. coli expressed in nmol
Table 4. Enzyme production by tested E. coli expressed in nmol
Strain 1 3 9 10 11 12 13 17
Ec3298/1 10 5 5 20 20 5 5 5
Ec3298/2 10 5 5 20 20 5 10 5
Ec3298/3 10 5 5 20 30 5 10 5
Ec3298/4 20 5 5 20 30 10 10 5
Ec3098/1 10 5 5 20 20 5 5 5
Ec3098/2 10 5 5 10 20 5 5 5
Ec3152 20 10 5 20 20 5 5 5
Ec3276 20 5 5 20 20 5 20 5
Ec3419/1 20 5 5 20 20 5 5 5
Ec3419/2 20 5 5 10 20 5 10 5
Ec3419/3 10 5 5 10 20 5 10 5
Ec3419/4 10 5 5 10 10 5 5 5
Ec3419/6 20 10 10 20 20 5 5 5
Ec7162/2 20 5 5 10 20 5 5 5
Ec7612/4 20 5 5 30 30 5 5 30
Ec3477/1 20 5 5 20 20 5 5 5
1-alkalic phosphatase, 3-esterase lipase (C8), 9-α chymotrypsin, 10-acidic phosphatase, 11-Naftol-AS-BI-phospho-hydrolase, 12-α-galactosidase, 13-β-galactosidase, 14-β-glucuronidase, 15-α-glucosidase, 17-N-acetyl-β-glucosaminidase. In case of the enzymes 2-esterase (C4), 4-lipase (C14),5- leucine arylamidase, 6- valine arylamidase, 7-cystine arylamidase, 8-trypsin, 14-β-glucuronidase, 15-α-glucosidase, 16-β-glucos idase,18-α mannosidase, and 19-α-fucosidase the reached values were 5 nmol.
Table 5. Susceptibility to postbiotic substance PS (Ent-like) 412 in arbitrary unit per ml) and herbal essential oils of pig-derived E. coli (inhibitory zone in diameter - mm).
Table 5. Susceptibility to postbiotic substance PS (Ent-like) 412 in arbitrary unit per ml) and herbal essential oils of pig-derived E. coli (inhibitory zone in diameter - mm).
Strain Oregano Thyme Sage Coriander PS (Ent) 412
Ec3298/1 35 21 15 21 800 h
Ec3298/2 22 27 24 31 100
Ec3298/3 19 10 20 10 1600
Ec3298/4 30 21 19 19 6400
Ec3098/1 30 21 21 15 -
Ec3098/2 30 15 13 10 -
Ec3152 30 24 13 19 -
Ec3276 36 14 10 15 -
Ec3419/1 16 20 9 10 3200
Ec3419/2 30 5 10 12 -
Ec3419/3 23 25 10 7 1600
Ec3419/4 27 20 15 10 -
Ec3419/6 20 20 10 12 -
Ec7162/2 20 15 10 10 -
Ec7612/4 21 14 10 10 -
Ec3477/1 35 13 10 10 -
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated